Chi Xun, Shetty Shwetha K, Shows Hannah W, Hjelmaas Alexander J, Malcolm Emily K, Davies Brandon S J
From the Department of Biochemistry, Fraternal Order of Eagles Diabetes Research Center and Obesity Research and Education Initiative, University of Iowa, Iowa City, Iowa 52242.
From the Department of Biochemistry, Fraternal Order of Eagles Diabetes Research Center and Obesity Research and Education Initiative, University of Iowa, Iowa City, Iowa 52242
J Biol Chem. 2015 May 8;290(19):11865-77. doi: 10.1074/jbc.M114.623769. Epub 2015 Mar 25.
The release of fatty acids from plasma triglycerides for tissue uptake is critically dependent on the enzyme lipoprotein lipase (LPL). Hydrolysis of plasma triglycerides by LPL can be disrupted by the protein angiopoietin-like 4 (ANGPTL4), and ANGPTL4 has been shown to inactivate LPL in vitro. However, in vivo LPL is often complexed to glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) on the surface of capillary endothelial cells. GPIHBP1 is responsible for trafficking LPL across capillary endothelial cells and anchors LPL to the capillary wall during lipolysis. How ANGPTL4 interacts with LPL in this context is not known. In this study, we investigated the interactions of ANGPTL4 with LPL-GPIHBP1 complexes on the surface of endothelial cells. We show that ANGPTL4 was capable of binding and inactivating LPL complexed to GPIHBP1 on the surface of endothelial cells. Once inactivated, LPL dissociated from GPIHBP1. We also show that ANGPTL4-inactivated LPL was incapable of binding GPIHBP1. ANGPTL4 was capable of binding, but not inactivating, LPL at 4 °C, suggesting that binding alone was not sufficient for ANGPTL4's inhibitory activity. We observed that although the N-terminal coiled-coil domain of ANGPTL4 by itself and full-length ANGPTL4 both bound with similar affinities to LPL, the N-terminal fragment was more potent in inactivating both free and GPIHBP1-bound LPL. These results led us to conclude that ANGPTL4 can both bind and inactivate LPL complexed to GPIHBP1 and that inactivation of LPL by ANGPTL4 greatly reduces the affinity of LPL for GPIHBP1.
血浆甘油三酯中的脂肪酸释放以供组织摄取,这一过程严重依赖脂蛋白脂肪酶(LPL)。血管生成素样蛋白4(ANGPTL4)可干扰LPL对血浆甘油三酯的水解作用,并且在体外实验中,ANGPTL4已被证明可使LPL失活。然而,在体内,LPL常与毛细血管内皮细胞表面的糖基磷脂酰肌醇锚定的高密度脂蛋白结合蛋白1(GPIHBP1)形成复合物。GPIHBP1负责将LPL转运穿过毛细血管内皮细胞,并在脂肪分解过程中将LPL锚定在毛细血管壁上。在此背景下,ANGPTL4如何与LPL相互作用尚不清楚。在本研究中,我们调查了ANGPTL4与内皮细胞表面LPL - GPIHBP1复合物的相互作用。我们发现,ANGPTL4能够结合并使内皮细胞表面与GPIHBP1形成复合物的LPL失活。一旦失活,LPL就会从GPIHBP1上解离。我们还发现,被ANGPTL4失活的LPL无法再结合GPIHBP1。ANGPTL4在4℃时能够结合LPL,但无法使其失活,这表明单纯的结合不足以产生ANGPTL4的抑制活性。我们观察到,尽管ANGPTL4的N端卷曲螺旋结构域自身以及全长ANGPTL4与LPL的结合亲和力相似,但N端片段在使游离的和与GPIHBP1结合的LPL失活方面更具效力。这些结果使我们得出结论:ANGPTL4既能结合并使与GPIHBP1形成复合物的LPL失活,而且ANGPTL4使LPL失活会极大降低LPL对GPIHBP1的亲和力。